4/12/2013

Participants taking plavastatin showed the lowest risk of new-onset diabetes, while atorvastatin and rosuvastatin were associated with intermediate and higher risk, compared with people in a placebo group, a meta-analysis in The American Journal of Cardiology revealed.

Related Summaries